Collagen family as promising biomarkers and therapeutic targets in cancer

L Necula, L Matei, D Dragu, I Pitica, A Neagu… - International Journal of …, 2022 - mdpi.com
Despite advances in cancer detection and therapy, it has been estimated that the incidence
of cancers will increase, while the mortality rate will continue to remain high, a fact explained …

The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature

A Fejza, G Carobolante, E Poletto, L Camicia… - Frontiers in …, 2023 - frontiersin.org
Introduction Immune-checkpoint inhibitors (ICIs) have emerged as a core pillar of cancer
therapy as single agents or in combination regimens both in adults and children …

Identification and verification of potential biomarkers in gastric cancer by integrated bioinformatic analysis

C Sun, Y Chen, NH Kim, S Lowe, S Ma, Z Zhou… - Frontiers in …, 2022 - frontiersin.org
Background: Gastric cancer (GC) is a common cancer with high mortality. This study aimed
to identify its differentially expressed genes (DEGs) using bioinformatics methods. Methods …

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients

H Zhu, X Hu, S Feng, L Gu, Z Jian, N Zou… - Frontiers in …, 2022 - frontiersin.org
Glioma is the most common primary brain tumor in the human brain. The present study was
designed to explore the expression of PIMREG in glioma and its relevance to the …

The oncogenic role of tubulin alpha-1c chain in human tumours

X Hu, H Zhu, B Chen, X He, Y Shen, X Zhang, Y Xu… - BMC cancer, 2022 - Springer
Tubulin alpha-1c chain (TUBA1C), a subtype of α-tubulin, has been shown to be involved in
cell proliferation and cell cycle progression in several cancers and to influence cancer …

Explainable multilayer graph neural network for cancer gene prediction

M Chatzianastasis, M Vazirgiannis, Z Zhang - Bioinformatics, 2023 - academic.oup.com
Motivation The identification of cancer genes is a critical yet challenging problem in cancer
genomics research. Existing computational methods, including deep graph neural networks …

Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation

W Zhao, Y Chang, Z Wu, X Jiang, Y Li, R Xie, D Fu… - PeerJ, 2023 - peerj.com
Background Phosphatidylinositol binding clathrin assembly protein interacting mitotic
regulator (PIMREG) expression is upregulated in a variety of cancers. However, its potential …

Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

X Hu, H Zhu, S Feng, C Wang, Y Ye, X Xiong - Frontiers in Genetics, 2022 - frontiersin.org
Liver hepatocellular carcinoma (LIHC) is a malignancy with a high mortality and morbidity
rate worldwide. However, the pathogenesis of LIHC has still not been thoroughly studied …

COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk

X Chen, C Ma, Y Li, Y Liang, T Chen, D Han, D Luo… - Oncogene, 2024 - nature.com
Triple-negative breast cancer (TNBC) is an exceptionally aggressive subtype of breast
cancer. Despite the recognized interplay between tumors and tumor-associated …

ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma

X Hu, D Li, H Zhu, T Yu, X Xiong, X Xu - BMC Medical Genomics, 2023 - Springer
Hepatocellular carcinoma (HCC) is one of the deadliest malignancies worldwide, with late
detection, ineffective treatment and poor overall survival. Immunotherapy, including immune …